Recombinant pseudoadenoviral influenza vaccine (NantPharma)

N/A

Report date: 2024/12/11 10:09:23

Base Information

Drug NameRecombinant pseudoadenoviral influenza vaccine (NantPharma)

Drug Alias NameAdeVac-Flu

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesNantpharma Llc

China Registration ClassN/A

Develop Information

Active CompaniesNantpharma Llc

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeJ07BB